Singhal A, Jie L, Kumar P, Hong G, Leow M, Paleja B, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014;6:263ra159 pubmed publisher

Voruganti S, Yamsani S, Yamsani M. Effect of silibinin on the pharmacokinetics of nitrendipine in rabbits. Eur J Drug Metab Pharmacokinet. 2014;39:277-81 pubmed publisher

Bogatcheva P, Balezina O. Multidirectional effects of calmodulin kinase II on transmitter release in mature and newly formed mouse motor synapses. Bull Exp Biol Med. 2013;154:316-9 pubmed

Iakovenko I, Zhirnov V, Kozachenko O, Shablykin O, Brovarets V. [Participation of proteinkinase CK2 in regulation of human erythrocytes plasma membrane redox system activity: relative contribution of ca(2+)-dependent and ca(2+)-independent mechanisms of its activation]. Ukr Biokhim Zh (1999). 2012;84:55-61 pubmed

Steger F, Hautmann M, Kölbl O. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?. Radiat Oncol. 2012;7:212 pubmed publisher

Gaydukov A, Marchenkova A, Balezina O. Involvement of basal and calcium-activated protein kinase C in neurotransmitter secretion in mouse motor synapses. Bull Exp Biol Med. 2012;153:820-3 pubmed

Gaydukov A, Marchenkova A, Balezina O. Facilitation of neurotransmitter release in mouse motor synapses in different modes of protein kinase C activation. Bull Exp Biol Med. 2012;153:415-8 pubmed

Mitręga K, Varghese B, Porc M, Krzeminski T. Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine. Pharmacol Res. 2012;66:300-8 pubmed publisher

Wu J, Xia D, van den Berg F, Amigo J, Rades T, Yang M, et al. A novel image analysis methodology for online monitoring of nucleation and crystal growth during solid state phase transformations. Int J Pharm. 2012;433:60-70 pubmed publisher

Zhang X, Ma Y, Zhang L, Zhu J, Jin F. The development of a novel dry powder inhaler. Int J Pharm. 2012;431:45-52 pubmed publisher

Bergeron A, Bergeron M, Garofolo F. Confirmation of no impact from different anticoagulant counter ions on bioanalytical method. Bioanalysis. 2012;4:897-908 pubmed publisher

Quan P, Shi K, Piao H, Piao H, Liang N, Xia D, et al. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability. Int J Pharm. 2012;430:366-71 pubmed publisher

Xia D, Wu J, Cui F, Qu H, Rades T, Rantanen J, et al. Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers. Eur J Pharm Sci. 2012;46:446-54 pubmed publisher

Liu Y, Wang Z, Sun J, Wang Y, He Z. Ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of nitrendipine in dog plasma and its application to a pharmacokinetic study of a solid self-emulsifying pellet formulation. Arzneimittelforschung. 2011;61:674-80 pubmed publisher

Voruganti S, Yamsani S, Ravula S, Gannu R, Yamsani M. Effect of pomegranate juice on intestinal transport and pharmacokinetics of nitrendipine in rats. Phytother Res. 2012;26:1240-5 pubmed publisher

Grall A, Guaguere E, Planchais S, Grond S, Bourrat E, Hausser I, et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat Genet. 2012;44:140-7 pubmed publisher

Sun H. Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism. Bioorg Med Chem Lett. 2012;22:989-95 pubmed publisher

Voruganti S, Rapolu K, Tota S, Yamsani S, Yamsani M. Effect of pomegranate juice on the pharmacokinetics of nitrendipine in rabbits. Eur J Drug Metab Pharmacokinet. 2012;37:77-81 pubmed publisher

Shang D, Wang X, Zhao X, Huang F, Tian G, Lu W, et al. Simultaneous determination of nitrendipine and hydrochlorothiazide in spontaneously hypertensive rat plasma using HPLC with on-line solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:3459-64 pubmed publisher

Quan P, Xia D, Piao H, Piao H, Shi K, Jia Y, et al. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation. AAPS PharmSciTech. 2011;12:1136-43 pubmed publisher

Shi X, Liu M, Sun M, Wang Q, Liu W, Cao D. Development of a LC-ESI-MS3 method for determination of nitrendipine in human plasma. J Pharm Biomed Anal. 2011;56:1101-5 pubmed publisher

Aktay G, Emre M, Polat A. Influence of dihydropyridine calcium antagonist nitrendipine on benzo(a)pyrene-induced oxidative stress. Arch Pharm Res. 2011;34:1171-5 pubmed publisher

Xia D, Ouyang M, Wu J, Jiang Y, Piao H, Sun S, et al. Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism. Pharm Res. 2012;29:158-69 pubmed publisher

Zhang Y, Cao Y, Wang Q, Zheng L, Zhang J, He L. A potential calcium antagonist and its antihypertensive effects. Fitoterapia. 2011;82:988-96 pubmed publisher

Manjunath K, Venkateswarlu V, Hussain A. Preparation and characterization of nitrendipine solid lipid nanoparticles. Pharmazie. 2011;66:178-86 pubmed

Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda Lucena A. QSAR-based permeability model for drug-like compounds. Bioorg Med Chem. 2011;19:2615-24 pubmed publisher

Miyazaki T, Aso Y, Yoshioka S, Kawanishi T. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP. Int J Pharm. 2011;407:111-8 pubmed publisher

Sinha N, Sen S. Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. Eur J Med Chem. 2011;46:618-30 pubmed publisher

Paris D, Bachmeier C, Patel N, Quadros A, Volmar C, Laporte V, et al. Selective antihypertensive dihydropyridines lower A? accumulation by targeting both the production and the clearance of A? across the blood-brain barrier. Mol Med. 2011;17:149-62 pubmed publisher

Sotnikov O, Vasiagina N, Rybakova G, Chepur S. Inhibition of contractions of nerve processes in calcium-free medium. Bull Exp Biol Med. 2010;149:265-8 pubmed

Talevi A, Goodarzi M, Ortiz E, Duchowicz P, Bellera C, Pesce G, et al. Prediction of drug intestinal absorption by new linear and non-linear QSPR. Eur J Med Chem. 2011;46:218-28 pubmed publisher

Reimão J, Scotti M, Tempone A. Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study. Bioorg Med Chem. 2010;18:8044-53 pubmed publisher

. [Isolated systolic hypertension threatens the heart and the brain. Fixed combination optimizes blood pressure control and offers clear prognostic advantage]. MMW Fortschr Med. 2010;152:50-1 pubmed

Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, et al. Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pai. Bioorg Med Chem. 2010;18:7675-99 pubmed publisher

Navarrete Vazquez G, Hidalgo Figueroa S, Torres Piedra M, Vergara Galicia J, Rivera Leyva J, Estrada Soto S, et al. Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives. Bioorg Med Chem. 2010;18:3985-91 pubmed publisher

Chang C, Cao S, Kang S, Kai L, Tian X, Pandey P, et al. Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2. Bioorg Med Chem. 2010;18:3147-58 pubmed publisher

Baraldi P, Preti D, Materazzi S, Geppetti P. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J Med Chem. 2010;53:5085-107 pubmed publisher

Prado Prado F, Garcia Mera X, González Díaz H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem. 2010;18:2225-2231 pubmed publisher

Guerra A, Campillo N, Paez J. Neural computational prediction of oral drug absorption based on CODES 2D descriptors. Eur J Med Chem. 2010;45:930-40 pubmed publisher

Kruhlak N, Choi S, Contrera J, Weaver J, Willard J, Hastings K, et al. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicol Mech Methods. 2008;18:217-27 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Du Cuny L, Song Z, Moses S, Powis G, Mash E, Meuillet E, et al. Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorg Med Chem. 2009;17:6983-92 pubmed publisher

Varma M, Feng B, Obach R, Troutman M, Chupka J, Miller H, et al. Physicochemical determinants of human renal clearance. J Med Chem. 2009;52:4844-52 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Jia L, Sun H. Support vector machines classification of hERG liabilities based on atom types. Bioorg Med Chem. 2008;16:6252-60 pubmed publisher

Obach R, Lombardo F, Waters N. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 2008;36:1385-405 pubmed publisher

Williams A, Sarkar S, Cuddon P, Ttofi E, Saiki S, Siddiqi F, et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4:295-305 pubmed publisher

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Tobita M, Nishikawa T, Nagashima R. A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorg Med Chem Lett. 2005;15:2886-90 pubmed

Siddiqui M, Plosker G. Fixed-dose combination enalapril/nitrendipine: a review of its use in mild-to-moderate hypertension. Drugs. 2004;64:1135-48 pubmed

Trost B, Weidmann P. Effects of nitrendipine and other calcium antagonists on glucose metabolism in man. J Cardiovasc Pharmacol. 1984;6 Suppl 7:S986-95 pubmed

Goa K, Sorkin E. Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs. 1987;33:123-55 pubmed

Hasegawa G. Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders. Clin Pharm. 1988;7:97-108 pubmed

Vanov S, Pun E, Taylor R. The safety of nitrendipine in the treatment of essential hypertension--a review of 61 clinical studies. Angiology. 1988;39:113-22 pubmed

Byyny R. Epidemiologic aspects of elderly hypertensive patients and the results of treatment with nitrendipine. J Cardiovasc Pharmacol. 1989;14 Suppl 10:S27-32; discussion S59-62 pubmed

Zanchetti A. Nitrendipine and ACE inhibitors. J Cardiovasc Pharmacol. 1988;12 Suppl 4:S80-5 pubmed

Mac Carthy E. Combination therapy of hypertension with beta-adrenoceptor blockers and the calcium channel antagonist nitrendipine. J Cardiovasc Pharmacol. 1988;12 Suppl 4:S76-9 pubmed

Eichelbaum M, Mikus G, Mast V, Fischer C, Kuhlmann U, Machleidt C. Pharmacokinetics and pharmacodynamics of nitrendipine in healthy subjects and patients with kidney and liver disease. J Cardiovasc Pharmacol. 1988;12 Suppl 4:S6-10 pubmed

Hulthen U, Katzman P. Review of long-term trials with nitrendipine. J Cardiovasc Pharmacol. 1988;12 Suppl 4:S11-5 pubmed

Kazda S, Hirth C, Stasch J. Diuretic effect of nitrendipine contributes to its antihypertensive efficacy: a review. J Cardiovasc Pharmacol. 1988;12 Suppl 4:S1-5 pubmed

Santiago T, Lopez L. Nitrendipine: a new dihydropyridine calcium-channel antagonist for the treatment of hypertension. DICP. 1990;24:167-75 pubmed

Ferrara L, Marotta T. Nitrendipine and metabolic balance. J Cardiovasc Pharmacol. 1991;18 Suppl 5:S19-21 pubmed

Ruilope L. Renal effects of nitrendipine. J Cardiovasc Pharmacol. 1991;18 Suppl 5:S10-3 pubmed

Mancini M, Marotta T, Ferrara L. Metabolic neutrality in nitrendipine therapy. J Cardiovasc Pharmacol. 1991;18 Suppl 1:S30-3 pubmed